Business Description
Pacific Biosciences of California Inc
NAICS : 325413
SIC : 3845
ISIN : US69404D1081
Description
Pacific Biosciences of California Inc is a biotechnology company focused on the design, development, and commercialization of tools for biological research. The company develops sequencing systems to assist in resolving genetically complex problems. Its sequencing systems provide access to a wide range of applications and are designed for expandable improvements to performance capability. The majority of the company's revenue is derived from North America, followed by Asia and Europe.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.89 | |||||
| Equity-to-Asset | 0.35 | |||||
| Debt-to-Equity | 1.46 | |||||
| Debt-to-EBITDA | -3.27 | |||||
| Piotroski F-Score | 2/9 | |||||
| Altman Z-Score | -0.24 | |||||
| Beneish M-Score | -2.54 | |||||
| WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -1.4 | |||||
| 3-Year EBITDA Growth Rate | -38.9 | |||||
| 3-Year EPS without NRI Growth Rate | -36.5 | |||||
| 3-Year FCF Growth Rate | -32.9 | |||||
| 3-Year Book Growth Rate | 90.6 | |||||
| Future 3-5Y Total Revenue Growth Rate | 34.71 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 19.94 | |||||
| 9-Day RSI | 25.26 | |||||
| 14-Day RSI | 29.28 | |||||
| 6-1 Month Momentum % | 6.44 | |||||
| 12-1 Month Momentum % | 88.95 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.45 | |||||
| Quick Ratio | 3.2 | |||||
| Cash Ratio | 3.06 | |||||
| Days Inventory | 185.5 | |||||
| Days Sales Outstanding | 61.05 | |||||
| Days Payable | 51.22 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -13.9 | |||||
| Shareholder Yield % | 0.24 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 30.1 | |||||
| Operating Margin % | -207.35 | |||||
| Net Margin % | -218.43 | |||||
| ROE % | -49.79 | |||||
| ROA % | -17.34 | |||||
| ROIC % | -28.48 | |||||
| ROC (Joel Greenblatt) % | -375.61 | |||||
| ROCE % | -18.49 | |||||
| Years of Profitability over Past 10-Year | 1 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 13.69 | |||||
| PB Ratio | 3.23 | |||||
| EV-to-EBIT | -7.2 | |||||
| EV-to-Forward-EBIT | -8.02 | |||||
| EV-to-EBITDA | -7.66 | |||||
| EV-to-Forward-EBITDA | -8.66 | |||||
| EV-to-Revenue | 15.02 | |||||
| EV-to-Forward-Revenue | 8.45 | |||||
| EV-to-FCF | -8.53 | |||||
| Price-to-Median-PS-Value | 1.41 | |||||
| Earnings Yield (Greenblatt) % | -13.89 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:PACB
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Pacific Biosciences of California Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 146.137 | ||
| EPS (TTM) ($) | -1.35 | ||
| Beta | 1.74 | ||
| Volatility % | 78.37 | ||
| 14-Day RSI | 29.28 | ||
| 14-Day ATR ($) | 0.549136 | ||
| 20-Day SMA ($) | 10.1595 | ||
| 12-1 Month Momentum % | 88.95 | ||
| 52-Week Range ($) | 4.97 - 14.55 | ||
| Shares Outstanding (Mil) | 250.56 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Pacific Biosciences of California Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Pacific Biosciences of California Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Pacific Biosciences of California Inc Frequently Asked Questions
What is Pacific Biosciences of California Inc(PACB)'s stock price today?
The current price of PACB is $8.27. The 52 week high of PACB is $14.55 and 52 week low is $4.97.
When is next earnings date of Pacific Biosciences of California Inc(PACB)?
The next earnings date of Pacific Biosciences of California Inc(PACB) is 2023-11-07 Est..
Does Pacific Biosciences of California Inc(PACB) pay dividends? If so, how much?
Pacific Biosciences of California Inc(PACB) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers